Longitudinal growth of infants born to HIV-1-infected mothers in Belo Horizonte, Brazil

Abstract Objective To prospectively evaluate growth parameters assessed by weight and length in infected and uninfected infants born to HIV-1-infected mothers and followed from birth to 18 months. Methods A cohort consisting of ninety-seven uninfected and forty-two infected infants born to HIV-infected mothers enrolled from 1995 to 2004, and admitted during their first 3 months of life at a referral Pediatric AIDS Clinic in Belo Horizonte, Brazil. Infants were followed until 18 months of age. Data were analysed using mixed-effects linear regression models for weight and length fitted by restricted maximum likelihood. Results Infected infants contributed to 466 weight and 411 recumbent length measurements. Uninfected infants provided 924 weight and 907 length measurements. Mean birth weight and length were similar in both groups, 3·1 (sd 0·4) and 3·0 (sd 0·5) kg, and 48·7 (sd 1·4) and 48·8 (sd 2·9) cm for uninfected and infected infants, respectively. However, HIV-1 infection had an early impact in growth impairment: at 6 months of age, HIV-infected children were 1 kg lighter and 2 cm shorter than the uninfected. Conclusions Growth faltering in weight, but not length, in HIV-infected children in Brazil is more marked than that reported in a European cohort, probably reflecting background nutritional deficiencies and concomitant infections. In these settings, early and aggressive nutritional management in HIV-1-infected infants should be a priority intervention associated with the antiretroviral therapy.

[1]  D. Tayloe,et al.  Pediatrics , 1927, The Indian Medical Gazette.

[2]  J. Bellón,et al.  Impact on Weight and Height With the Use of HAART in HIV-Infected Children , 2007, The Pediatric infectious disease journal.

[3]  J. Lindsey,et al.  Growth of Human Immunodeficiency Virus-Infected Children Receiving Highly Active Antiretroviral Therapy , 2005, The Pediatric infectious disease journal.

[4]  D. Purdie Statistical Methods in Medical Research, 4th edn , 2003 .

[5]  V. Carey,et al.  Growth velocity assessment in paediatric AIDS: smoothing, penalized quantile regression and the definition of growth failure , 2004, Statistics in medicine.

[6]  M. Newell,et al.  Height, weight, and growth in children born to mothers with HIV-1 infection in Europe. , 2003, Pediatrics.

[7]  N. Shaffer,et al.  Survival, disease manifestations, and early predictors of disease progression among children with perinatal human immunodeficiency virus infection in Thailand. , 2002, Pediatrics.

[8]  Mínistério da Saúde Guia de Tratamento Clínico da Infecção Pelo HIV em Crianças , 1998 .

[9]  V. Carey,et al.  Mixed-Effects Models in S and S-Plus , 2001 .

[10]  A. R. Frisancho Physical Status: The Use and Interpretation of Anthropometry , 1996, The American Journal of Clinical Nutrition.

[11]  R. de Groot,et al.  Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. , 2002, Pediatrics.

[12]  P. Diggle Analysis of Longitudinal Data , 1995 .

[13]  R. Bosch,et al.  Growth failure as a prognostic indicator of mortality in pediatric HIV infection. , 1997, Pediatrics.

[14]  L. Kalish,et al.  Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. Women and Infants Transmission Study Group. , 1996, The Journal of pediatrics.

[15]  J. Wang,et al.  Growth velocity, fat-free mass and energy intake are inversely related to viral load in HIV-infected children. , 2000, The Journal of nutrition.